Luckwel Pharmaceuticals Inc LWEL:Grey Market

RT Quote | Exchange | USD
Last | EST
UNCH (UNCH)
52 week range
3.50 - 3.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High3.50
  • 52 Week High Date10/13/21
  • 52 Week Low3.50
  • 52 Week Low Date10/13/21

Key Stats

  • Market Cap-
  • Shares Out147.16M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High3.50
  • 52 Week High Date10/13/21
  • 52 Week Low3.50
  • 52 Week Low Date10/13/21
  • Market Cap-
  • Shares Out147.16M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-434,980.00
  • ROE (TTM)-1,269.23%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-11.23%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Luckwel Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Luckwel Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies to combat HIV/AIDS, autoimmune diseases and infectious diseases. The Company’s pipelines include LWEL-2120 for the treatment of rheumatoid arthritis (RA); LWEL-2119 for the treatment of human immunodeficiency virus (HIV), and LWEL-2103 for the treatment of COVID-19.
Kingrich Lee
Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Sole Director
Address
125 CAMBRIDGE PARK DRIVE, SUITE 301
Cambridge, MA
02140
United States